| Schedule of earnings per share |
| | | | | | | | | | | | | | | | | | | | | | | | | Year Ended December 31, | | | | | | 2024 | | 2023 | | 2022 | | | | | | | | | | | | | | | | Financial Holding Company | | Financial Holding Company | | Investment Company | | Basic earnings per share: | | | | | | | | | | | Net income available to common shareholders | | | | | $ | 49,253 | | | $ | 45,875 | | | $ | 32,311 | | | Weighted-average basic shares outstanding | | | | | 24,945 | | | 24,263 | | | 24,198 | | | Basic earnings per share | | | | | $ | 1.97 | | | $ | 1.89 | | | $ | 1.34 | | | Diluted earnings per share: | | | | | | | | | | | Net income, for diluted earnings per share | | | | | $ | 49,253 | | | $ | 45,875 | | | $ | 32,311 | | | Add: Preferred dividends on dilutive Series A convertible preferred stock¹ | | | | | — | | | — | | | — | | | Net income, for diluted earnings per share | | | | | 49,253 | | | 45,875 | | | 32,311 | | | Total weighted-average basic shares outstanding | | | | | 24,945 | | | 24,263 | | | 24,198 | | | Add effect of dilutive restricted stock awards² | | | | | 241 | | | 85 | | | — | | | | | | | | | | | | | Total weighted-average diluted shares outstanding³ | | | | | 25,186 | | | 24,348 | | | 24,198 | | | Diluted earnings per share | | | | | $ | 1.96 | | | $ | 1.88 | | | $ | 1.34 | | | Anti-dilutive warrants, restricted stock awards, and Series A convertible preferred stock | | | | | 998 | | | 1,153 | | | — | | | | | | | | | | | | | | | | | | | | | |
1 For periods presented, the Series A convertible preferred stock was antidilutive and, therefore, the preferred dividends have not been added back to the numerator of Net income, for diluted earnings per share. 2 Incremental diluted shares from restricted stock awards under the treasury stock method. 3 For the year ended ended December 31, 2024 and December 31, 2023, the Warrants were not included in the diluted share count because the results would have been anti-dilutive under the if-converted method.
|